About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Orion Corporation image

Orion Corporation

Rank#1699
Market Cap13.00B
CountryFinland
Summary
History
Mission
Vision
References
Summaryarrow
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
Historyarrow

Orion was founded on September 21, 1917 by pharmacists Onni Turpeinen, Eemil Tuurala and Wikki Valkama. Before founding Orion, they worked in a pharmaceutical-chemical factory called Medica. The first premises of the new company were found in a courtyard building in Helsinki's Kruununhaa, Mariankatu 24, i.e. Asunto Oy Mars star. Among the first products of the apothecary were Bellistol gun oil and dulcine. Pediatrician Arvo Ylppö played a significant role starting in the 1920s.Orion's diagnostics business was previously concentrated in the Orion Diagnostica profit unit, which was sold to a private equity investor in April 2018. The diagnostics business included the development, manufacture and marketing of diagnostic tests and hygiene tests. Orion Diagnostica changed its name in November 2019 and is now Aidian.

Missionarrow
Mission to build well-being
Visionarrow
Our vision is to be the global leader in medical diagnostics, allowing clinicians to make more informed decisions and healthcare providers to deliver the most efficient care.
Referencesarrow

https://en.wikipedia.org/wiki/Orion_Corporation

https://in.investing.com/equities/orion-corp

https://finance.yahoo.com/quote/ORNBV.HE/profile?p=ORNBV.HE

https://www.comparably.com/companies/orion-corporation/mission

https://www.crunchbase.com/organization/orion-corporation

https://companiesmarketcap.com/

https://www.orion.fi

Share

Leadership team
D
Dr. Liisa Hurme (Pres, CEO & Chairman of Exec. Management Board)
M
Mr. Timo Lappalainen (Advisor)
M
Mr. Jari Karlson M.Sc., M.Sc. (Econ.) (CFO, Sr. VP of Animal Health & Member of the Exec. Management Board)
Products / Services
Pharmaceutical
Number of Employees
1,000 - 20,000
Address
Espoo, Southern Finland, Finland
Established
1970-01-01
Net Income
S_100M_500M
Revenue
$1B+
Traded as
ORNAV.HE
Website
https://www.orion.fi
Social Media
linkedinfacebookx
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo